{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T08:07:52Z","timestamp":1774426072158,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12098-020-03538-y","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T09:09:43Z","timestamp":1605690583000},"page":"582-585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lessons from Wolfram Syndrome: Initiation of DDAVP Therapy Causes Renal Salt Wasting Due to Elevated ANP\/BNP Levels, Rescued by Fludrocortisone Treatment"],"prefix":"10.1007","volume":"88","author":[{"given":"Kleanthis","family":"Kleanthous","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirini","family":"Maratou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dora","family":"Spyropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Dermitzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasios","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Zoupanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Moutsatsou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Mastorakos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiko","family":"Urano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6083-3560","authenticated-orcid":false,"given":"Dimitrios T.","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"3538_CR1","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12967-019-1993-1","volume":"17","author":"MT Pallotta","year":"2019","unstructured":"Pallotta MT, Tascini G, Crispoldi R, et al. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives. J Transl Med. 2019;17:238.","journal-title":"J Transl Med"},{"key":"3538_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/pr.2018.17","volume":"83","author":"L Rigoli","year":"2018","unstructured":"Rigoli L, Bramanti P, Di Bella C, De Luca F. Genetic and clinical aspects of Wolfram syndrome 1, a severe neurodegenerative disease. Pediatr Res. 2018;83:921\u20139.","journal-title":"Pediatr Res"},{"key":"3538_CR3","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1172\/JCI39678","volume":"120","author":"SG Fonseca","year":"2010","unstructured":"Fonseca SG, Ishigaki S, Oslowski CM, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest. 2010;120:744\u201355.","journal-title":"J Clin Invest"},{"key":"3538_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.tips.2019.07.011","volume":"40","author":"D Abreu","year":"2019","unstructured":"Abreu D, Urano F. Current landscape of treatments for Wolfram syndrome. Trends Pharmacol Sci. 2019;40:711\u20134.","journal-title":"Trends Pharmacol Sci"},{"key":"3538_CR5","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1515\/JPEM.2007.20.10.1145","volume":"20","author":"DT Papadimitriou","year":"2007","unstructured":"Papadimitriou DT, Spiteri A, Pagnier A, et al. Mineralocorticoid deficiency in post-operative cerebral salt wasting. J Pediatr Endocrinol Metab. 2007;20:1145\u201350.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"3538_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/0039-128X(94)00021-4","volume":"60","author":"J M\u00fcller","year":"1995","unstructured":"M\u00fcller J. Aldosterone: the minority hormone of the adrenal cortex. Steroids. 1995;60:2\u20139.","journal-title":"Steroids"},{"key":"3538_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s12098-018-2640-1","volume":"85","author":"DT Papadimitriou","year":"2018","unstructured":"Papadimitriou DT, Spiteri A, Attilakos A, Papadimitriou A. Cerebral salt wasting complicated by central diabetes insipidus and growth hormone deficiency. Indian J Pediatr. 2018;85:580\u20131.","journal-title":"Indian J Pediatr"},{"key":"3538_CR8","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1002\/ccr3.2494","volume":"7","author":"DT Papadimitriou","year":"2019","unstructured":"Papadimitriou DT, Kleanthous K, Manolakos E, et al. A novel detrimental homozygous mutation in the WFS1 gene in two sisters from nonconsanguineous parents with untreated diabetes insipidus. Clin Case Rep. 2019;7:2355\u20137.","journal-title":"Clin Case Rep"},{"key":"3538_CR9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.diabet.2015.06.003","volume":"41","author":"DT Papadimitriou","year":"2015","unstructured":"Papadimitriou DT, Manolakos E, Bothou C, et al. Maternal uniparental disomy of chromosome 4 and homozygous novel mutation in the WFS1 gene in a paediatric patient with Wolfram syndrome. Diabetes Metab. 2015;41:433\u20135.","journal-title":"Diabetes Metab"},{"key":"3538_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ijcard.2018.12.069","volume":"280","author":"S Kasahara","year":"2019","unstructured":"Kasahara S, Sakata Y, Nochioka K, et al. Conversion formula from B-type natriuretic peptide to N-terminal proBNP values in patients with cardiovascular diseases. Int J Cardiol. 2019;280:184\u20139.","journal-title":"Int J Cardiol"},{"key":"3538_CR11","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00246-008-9258-4","volume":"30","author":"A Nir","year":"2009","unstructured":"Nir A, Lindinger A, Rauh M, et al. NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies. Pediatr Cardiol. 2009;30:3\u20138.","journal-title":"Pediatr Cardiol"},{"key":"3538_CR12","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/heart.89.8.875","volume":"89","author":"A Koch","year":"2003","unstructured":"Koch A, Singer H. Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart. 2003;89:875\u20138.","journal-title":"Heart"},{"key":"3538_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12882-015-0163-9","volume":"16","author":"N Ogawa","year":"2015","unstructured":"Ogawa N, Komura H, Kuwasako K, Kitamura K, Kato J. Plasma levels of natriuretic peptides and development of chronic kidney disease. BMC Nephrol. 2015;16:171.","journal-title":"BMC Nephrol"},{"key":"3538_CR14","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1253\/jcj.52.1450","volume":"52","author":"S Torikai","year":"1988","unstructured":"Torikai S. Factors influencing vascular and natriuretic responses to ANP. Jpn Circ J. 1988;52:1450\u20132.","journal-title":"Jpn Circ J"}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-020-03538-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-020-03538-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T15:06:18Z","timestamp":1621695978000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-020-03538-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1007\/s12098-020-03538-y","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]},"assertion":[{"value":"21 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Laboratory kits required for ANP measurements were privately funded by Pediatric Endocrine Clinics, directed by D.T.P.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Source of Funding"}}]}}